DoximityDOCS +1.25%82 EV-to-EBITDA is 14.21 as of Jul. 04, 2026, which is 68% below its 10-year median of 44.84. GuruFocus rates DOCS with a GF Score™ of 82/100 and a GF Value™ of $49.25 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 507 Healthcare Providers & Services companies, Doximity ranks worse than 61.54% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Doximity's enterprise value is $3,259.2 Mil.
Doximity's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $229.3 Mil. Therefore, Doximity's EV-to-EBITDA for today is 14.21.
The historical rank and industry rank for Doximity's EV-to-EBITDA or its related term are showing as below:
DOCS'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 12.92 Med: 44.84 Max: 173.39
Current: 14.21
During the past 8 years, the highest EV-to-EBITDA of Doximity was 173.39. The lowest was 12.92. And the median was 44.84.
DOCS's EV-to-EBITDA is ranked worse than 61.54% of 507
companies
in the Healthcare Providers & Services industry
Industry Median: 10.92
vs DOCS: 14.21
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Doximity (NYSE:DOCS) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Doximity's share price for today is $21.86.
Doximity's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.990.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Doximity's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Doximity's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Doximity EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Doximity's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Doximity's EV-to-EBITDA falls into.
Doximity's current Enterprise Value is $3,259.2 Mil.
Doximity's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $229.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Doximity (DOCS) has a EV-to-EBITDA of 14.21 as of Jul. 04, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Doximity. This is 68% below median its historical median of 44.84. Over the past decade, Doximity's EV-to-EBITDA has ranged from 12.92 to 173.39. According to the industry distribution chart, Doximity ranks #312 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 61.5%.
Is Doximity's EV-to-EBITDA too high?
Doximity's current EV-to-EBITDA of 14.21 is 68% below median its 10-year median of 44.84. Over the past 10 years, this metric has ranged from a low of 12.92 to a high of 173.39. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.92. Doximity's value of 14.21 is 30.1% above this industry median. Based on the distribution chart, Doximity ranks #312 out of 507 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Doximity has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Doximity's EV-to-EBITDA compare to WAY and PRVA?
According to the Healthcare Providers & Services industry distribution chart, Doximity ranks #312 out of 507 companies for EV-to-EBITDA. This places Doximity in the lower half of its industry. The industry median EV-to-EBITDA is 10.92. Doximity's value of 14.21 is 30.1% above this benchmark. Historically, Doximity's own EV-to-EBITDA has ranged from 12.92 to 173.39 over the past decade. While the company's 10-year median is 44.84 vs. the industry median of 10.92, Doximity has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.92, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Doximity's current EV-to-EBITDA of 14.21 is 30.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Doximity. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Doximity's current EV-to-EBITDA is 14.21, which is 68% below median its own 10-year median of 44.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doximity stock overvalued right now?
Based on GuruFocus' analysis, Doximity (DOCS) is currently considered Significantly Undervalued. The stock's GF Value™ is $49.25, compared to a current price of $21.86 — trading 55.6% below its estimated fair value. The current EV-to-EBITDA is 14.21, which is 68% below median its 10-year median of 44.84 and 30.1% above the Healthcare Providers & Services industry median of 10.92. Doximity's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Doximity (DOCS), the current EV-to-EBITDA is 14.21 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Doximity (DOCS) Overvalued in 2026?
Based on GuruFocus' analysis, Doximity stock appears to be undervalued.
The current stock price of $21.86 is trading 55.6% below its estimated GF Value™ of $49.25.
GuruFocus considers Doximity to be Significantly Undervalued.
Key valuation signals for DOCS:
EV-to-EBITDA: 14.21 (68% below median its 10-year median of 44.84)
GF Value™: $49.25 vs. price of $21.86 (55.6% below fair value)
Industry Position: 30.1% above the Healthcare Providers & Services median (#312 of 507)
No single metric tells the full story. See the DOCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
82GF Score
Get the complete analysis for DOCS
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DOCS has been successfully added to your 
